Acidic Topical Composition for FMD Lesion Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for acid-labile pathogens causing diseases like foot and mouth disease, scabby mouth, and hoof rot lack effective solutions for rapid pain relief and viral control, leading to slow recovery and transmission issues.
Innovation Solution
A topical composition with an acidic pH, containing local anesthetics like lignocaine and bupivacaine, and antiseptic agents like cetrimide, which provides immediate pain relief and viricidal properties, effectively treating and controlling acid-labile pathogens by forming a long-lasting barrier on affected areas.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for acid-labile pathogens, then animals receive basic care, but pain relief is insufficient and healing is slow
Solution Approach 1:
The patent changes the pH parameter of the treatment composition to acidic (pH 2-4), which matches the optimal condition for inactivating acid-labile pathogens. This parameter change enables the composition to rapidly inactivate viruses like FMD and ORF, significantly accelerating healing and reducing recovery time from weeks to days.
Solution Approach 2:
The patent creates a composite treatment composition that combines multiple active ingredients with complementary functions: an acidic agent (for pathogen inactivation), a local anesthetic (for immediate pain relief), and an antiseptic (for preventing secondary infections). This composite approach simultaneously addresses pain, infection control, and viral inactivation, dramatically improving healing effectiveness and reducing recovery time.
2Object-generated harmful factors
If acidic treatments are applied to inactivate viruses, then viral transmission is controlled, but pain and discomfort increase
Solution Approach 1:
The patent merges two previously separate treatment functions into a single composition: viral inactivation (through acidic pH) and pain relief (through local anesthetic). This unified composition is applied simultaneously, allowing the anesthetic to counteract the stinging sensation from the acid while the acid inactivates the virus, thus controlling transmission without prolonged pain.
Solution Approach 2:
The local anesthetic acts as an intermediary substance that mediates between the acidic antiviral agent and the animal's nervous system. It blocks pain signal transmission temporarily, allowing the acidic composition to work effectively on the virus without causing severe discomfort or distress to the animal.
3Adaptability or versatility
If multiple separate treatments are applied (antiseptics, anesthetics, antivirals), then comprehensive care is provided, but treatment complexity increases
Solution Approach 1:
The patent designs a universal multi-functional composition that performs multiple treatment roles simultaneously: acidic pH for viral inactivation, local anesthetic for pain relief, and antiseptic for infection prevention. This single composition replaces multiple separate treatments, simplifying the treatment protocol while maintaining comprehensive care for acid-labile pathogen infections.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly hastens healing, reduces viral transmission, and provides prolonged pain relief, demonstrating rapid improvement in animal behavior and lesion recovery, while minimizing secondary infections.
Implementation Method 1
a pathogenic disease caused by an acid-labile pathogen selected from foot and mouth disease (FMD), scabby mouth (Orf), Picornavirus, Parapoxvirus
Implementation Method 2
containing local anesthetics like lignocaine and bupivacaine, which provides immediate pain relief
Implementation Method 3
antiseptic agents like cetrimide, which provides immediate pain relief and viricidal properties
Data Source
Figure 1
Figure 2
AI summary
A method of treating a subject having a disease caused by a pathogen, preferably an acid-labile pathogen, said method comprising the step of applying to the subject a therapeutically effect amount of a topical composition having biocidal properties or both pain-relieving and biocidal properties. The composition can be used to treat or control bacterial, viral, fungal or infestational pathogens, and related diseases. The disease can be foot and mouth disease (FMD) or scabby mouth (orf), caused by an acid-labile virus. The topical composition can be used to treat hoof rot/footrot/foot abscess and viral lesions.